Pharmafile Logo

Report: Mexico’s drug market access landscape shake-up: What does it mean for pharma?

February 1, 2022 | LATAM, Market Access, Mexico, Pharma 

Rebeca Nana Barrantes and Tania Rodrigues outline what the shake-up in Mexico’s drug market access landscape means for pharma.

In the first issue of our new online report series, Access All Areas, experts Rebeca Nana Barrentes and Tania Rodrigues investigate what the shake-up in Mexico’s drug market access landscape means for pharma.

Download now: https://bit.ly/3L0EGGj

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard